Higher concentrations of many inflammatory markers, including CRP, IL-1β, IL-6, and TNF-a, have been linked with a higher risk of breast cancer [15,16,54] through the stimulation of angiogenesis, proliferation, migration, metastasis, and prevention of apoptosis. This evidence concerns the gene IL6 and breast carcinoma.